Investing Profile

Amel Tounsi

InvestorVC
Investment Manager at Noshaq
noshaq.beBrussels
Photo of Amel Tounsi, Noshaq

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Noshaq Network
13 CONNECTIONS
Solvay Brussels School Network
11 CONNECTIONS
Solvay Brussels School Network
11 CONNECTIONS
cb
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Amyl Therapeutics
Series ASep 2026$10M
Series ANov 2023$6M
Series AJun 2021$10M
$26M
Co-investors: Evren Ucok (Earlybird Venture Capital)
Research And Development Scientist Celyad OncologyPresent
R&D Scientist Celyad OncologyPresent
Project Leader Celyad OncologyPresent
Project Manager MaSTherCellPresent
Chief Operating Officer TexerePresent
PhD Student Ludwig Cancer ResearchPresent
Post Doctoral Fellow DKFZ German Cancer Research CenterPresent
Project Lead Celyad OncologyPresent
Project & Development Manager MaSTherCellPresent
Chief Operations Officer TexerePresent
Investment Manager NoshaqPresent
Chief Executive Officer Bridge2Health (B2H)Present
Université de STRASBOURG Master's Degree Cell/Cellular and Molecular Biology
Université de STRASBOURG Master en Biologie Cellulaire et Physiologie Neurobiologie et neurosciences
UCLouvain Master of Business Administration Health Services/Allied Health/Health Sciences, General
UCLouvain PhD Biomedical studies
UCLouvain Doctor of Philosophy Pharmaceutical Sciences
UCLouvain Doctorat Sciences biomédicales, général
Solvay Brussels School Accelerated Management Programme LEadership-Project Managment-Marketing-Accounting-Finance-Strategic Management
Institut Ressources formations PNL Certified NLP Master Neurolinguistic Programming
Solvay Brussels School EMBA Administration et gestion des affaires, général
Sign in with Google →
Sign in with Google →